Journal of Clinical Virology
Volume 47, Issue 1 , Pages 65-68 , January 2010

The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey

Received 4 June 2009 ,Revised 9 October 2009 ,Accepted 6 November 2009.

References 

  1. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res. 2004;64(3):145–160
  2. Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect. 2006;12(6):551–554
  3. Ergonul O, Celikbas A, Dokuzoguz B, Eren S, Baykam N, Esener H. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis. 2004;39(2):284–287
  4. Karti SS, Odabasi Z, Korten V, Yilmaz M, Sonmez M, Caylan R, et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis. 2004;19(8):1379–1384
  5. Ozkurt Z, Kiki I, Erol S, Erdem F, Yilmaz N, Parlak M, et al. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect. 2006;52(3):207–215
  6. Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H, et al. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol. 2005;54(4):385–389
  7. Yilmaz GR, Buzgan T, Torunoglu MA, Safran A, Irmak H, Com S, et al. A preliminary report on Crimean-Congo haemorrhagic fever in Turkey, March–June 2008. Euro Surveill. 2008;14(13):pii 18953
  8. Borio L, Inglesby T, Peters CJ, Schmaljohn AL, Hughes JM, Jahrling PB, et al. Haemorrhagic fever viruses as biological weapons. JAMA. 2002;287(18):2391–2405
  9. Koren G, King S, Knowlea S, Philips E. Ribavirin in the treatment of SARS: a new trick for an old drug?. Can Med Assoc J. 2003;168(10):1289–1292
  10. Goad JA, Nuyen J. Haemorrhagic fever viruses. Top Emerg Med. 2003;25(1):66–72
  11. Fisher-Hoch SP, Khan JA, Rehman S, Mirza S, Khurshid M, McCormick JB. Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet. 1995;346(8973):472–475
  12. Wray SK, Gilbert BE, Noall MW, Knight V. Mode of action of ribavirin: effect of nucleotide pool alterations on influenza virus ribonucleoprotein synthesis. Antiviral Res. 1985;5(1):29–37
  13. Wray SK, Gilbert BE, Knight V. Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro. Antiviral Res. 1985;5(1):39–48
  14. McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, et al. Lassa fever: effective therapy with ribavirin. N Engl J Med. 1986;314(1):20–26
  15. Paragas J, Whitehouse CA, Bray M, Endy TP. A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus. Antiviral Res. 2004;62(1):21–25
  16. Ergonul O. Treatment of Crimean-Congo hemorrhagic fever. Antiviral Res. 2008;78(1):125–131
  17. Mardani M, Jahromi MK. Crimean-Congo haemorrhagic fever. Arch Iranian Med. 2007;10(2):204–214
  18. Mardani M, Jahromi MK, Naieni KH, Zeinali M. The efficacy of oral ribavirin in the treatment of Crimean-Congo haemorrhagic fever in Iran. Clin Infect Dis. 2003;36(12):1613–1618
  19. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006;6(4):203–214
  20. Cevik MA, Elaldi N, Akinci E, Ongürü P, Erbay A, Buzgan T, et al. A preliminary study to evaluate the effect of intravenous ribavirin treatment on survival rates in Crimean-Congo hemorrhagic fever. J Infect. 2008;57(4):350–351
  21. Graci JD, Cameron CE. Mechanisms of action of ribavirin against distinct viruses. Rev Med Virol. 2006;16(1):37–48
  22. Heagy W, Crumpacker C, Lopez PA, Finberg RW. Inhibition of immune functions by antiviral drugs. J Clin Invest. 1991;87(6):1916–1924
  23. Izadi S, Salehi M. Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case–control study. Jpn J Infect Dis. 2009;62(1):11–15

PII: S1386-6532(09)00548-4

doi: 10.1016/j.jcv.2009.11.007

Journal of Clinical Virology
Volume 47, Issue 1 , Pages 65-68 , January 2010

Article Tools